MedTrace Logo

The Impact of SPC on Advanced Breast Cancer Patients

NCT03612934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2018-08-02

No results posted yet for this study

Summary

The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland. The length of the entire study will be 36 months.

Conditions

Interventions

PROCEDURE

Specialist Palliative Care

In the research, Specialist Palliative Care was provided according to the guidelines established by Mid-Western Health Board in a Report of the National Advisory Committee on Palliative Care as well as according to recommendations of Polish Society of Palliative Medicine and Polish National Healthcare Fund. In order to ensure interdisciplinary and integrated palliative care, a team of specialists was appointed. Team members were engaged in the process of treatment of each patient during the time of the study and applied their specialist skills according to the needs of the patients

Sponsors & Collaborators

  • Silesian University of Medicine

    lead OTHER

Principal Investigators

  • Jadwiga Jośko-Ochojska, prof · 4. Chair and Department of Medicine and Environmental Epidemiology Medical University of Silesia in Katowice

  • Łukasz Pietrzyńsi · 1. Medical University of Silesia, department of palliative medicine

Eligibility

Min Age
33 Years
Max Age
91 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-01
Primary Completion
2018-05-01
Completion
2018-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03612934 on ClinicalTrials.gov